| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
1,114,679,000
|
1,290,546,000
|
1,103,591,000
|
939,695,000
| | Cost of Revenue | 1,047,749,000 | 1,229,596,000 | 1,061,684,000 | 891,397,000 | | |
Gross Profit
|
66,930,000
|
60,949,000
|
41,907,000
|
48,299,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 1,091,136,000 | 1,268,494,000 | 1,090,280,000 | 919,085,000 | | | |
Operating Income or Loss
|
23,543,000
|
22,052,000
|
13,311,000
|
20,611,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 23,543,000 | 22,052,000 | 13,311,000 | 20,611,000 |
|
Interest Expense | (9,321,000) | (21,123,000) | (7,941,000) | (4,598,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 9,443,000 | 2,545,000 | 595,000 | 4,911,000 |
|
Minority Interest | 1,000 | 1,000 |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 14,753,000 | 7,574,000 | 13,641,000 | 16,740,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
14,753,000
|
7,574,000
|
13,641,000
|
16,740,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
1.77%